Patient-related factors: Multiparous patients with a past history of severe
preeclampsia are a high risk population which should be identified early i
n pregnancy. Selection on this criterion alone is however insufficient for
large scale screening and prevention because most of the susceptible women
are nulliparous. Search for a particular familial or personal history of va
scular disorders can be helpful. The usefulness of blood pressure measureme
nts during the second trimester has not been proven.
Markers: There is a significant association between pre-eclampsia and a lar
ge number of biological markers. No one assay can however fulfill the requi
rements for effective early screening because sensitivity is too low or the
rate of false positives is too high, or because the examination is too inv
asive or costly.
Doppler anomalies: Doppler exploration of the uterine arteries at 20 to 24
weeks gestation offers satisfactory sensitivity and specificity but the pos
itive predictive value is low. Persistence of a bilateral notch beyond 24 w
eeks considerably limits the number of false positives. More than half of t
he patients with this anomaly will develop hypertension during pregnancy. W
hile no one marker fulfills ail the prerequisites for effective screening,
a combination of several tests may be useful. hCG assay during the second t
rimester in association with Doppler exploration of the uterine arteries ap
pears to be a promising combination.
Prevention: Starting with these markers or risk factors, the goal is to dev
elop a prevention scheme using low-dose aspirin, the only evidence-based pr
eventive treatment to date. Further trials are required to test simultaneou
sly the predictive value and impact (versus placebo) of proposed strategies
.